Tomasj Heyman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tomasj heyman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tomasj Heyman Today - Breaking & Trending Today

Akero Therapeutics, Inc. (NASDAQ:AKRO) Director Sells $1,421,420.00 in Stock

Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) Director Tomas J. Heyman sold 26,000 shares of the stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $54.67, for a total transaction of $1,421,420.00. The transaction was disclosed in a filing with the SEC, which is available through this […] ....

Tomasj Heyman , Artisan Partners Limited Partnership , Akero Therapeutics Company Profile , Metlife Investment Management , Akero Therapeutics Inc , Canaccord Genuity Group , Alkeon Capital Management , Citigroup Inc , Akero Therapeutics , Get Rating , Director Tomas , Partners Limited Partnership , Capital Management , Life Investment Management , Tri Locum Partners , Akero Therapeutics Daily , Nasdaq Akro , Insider Trading , Nsider Trades ,

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Director Sells 26,000 Shares of Stock

Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) Director Tomas J. Heyman sold 26,000 shares of the company’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $54.67, for a total transaction of $1,421,420.00. The sale was disclosed in a document filed with the SEC, which is accessible […] ....

Tomasj Heyman , Citigroup Inc , Metlife Investment Management , Akero Therapeutics Company Profile , Akero Therapeutics Inc , Canaccord Genuity Group , Artisan Partners Limited Partnership , Alkeon Capital Management , Akero Therapeutics , Get Rating , Director Tomas , Therapeutics Trading Down , Partners Limited Partnership , Capital Management , Life Investment Management , Tri Locum Partners , Akero Therapeutics Daily ,

Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman

Dr. Michael Diem Steps Down from Board of DirectorsMALVERN, Pa. (BUSINESS WIRE) Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant gram-negative bacterial infections and viral infections, today announce. ....

Region Flamande , United States , Tomas Heyman , Tom Heyman , Jennifer Guinan , Tomasj Heyman , Janssen Pharmaceutica , Mike Diem , Michael Diem , Christopherj Burns , Venatorx Pharmaceuticals , Adagio Therapeutics Inc , University Of Antwerp , Drug Administration , Michael Diem Steps Down , Independent Director , Chief Executive , Venatorx Board , Ortho Pharmaceutical , Xilio Therapeutics , Legend Biotech , Akero Therapeutics , New Drug Application , Private Securities Litigation Reform Act , Venatorx Pharmaceutical ,

Xilio Therapeutics (XLO) Appoints Tomas J. Heyman to its Board

Xilio Therapeutics (XLO) Appoints Tomas J. Heyman to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John Maraganore , Tomasj Heyman , Myles Clouston , Paul Clancy , Alnylam Pharmaceuticals , Xilio Therapeutics Inc , Thomson Financial Corporate Services , Wall Street , Thomson Financial Corporate ,